CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
PRINCETON, N.J., Feb. 08, 2024 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that Dr. Phillip Chan, Chief Executive Officer, will present at the
Related news for (CTSO)
- CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen
- CytoSorbents Provides DrugSorb-ATR Regulatory Update
- CytoSorbents To Host Global Webinar on “Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb” in Recognition of World Sepsis Day
- CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference
- CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR